SELECT PUBLICATIONS
Benson AB et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004;22:3408-19. Abstract
De Gramont A et al. Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up of six years. Proc ASCO 2007;Abstract 4007.
Goldberg RM et al. Pooled analysis of safety and efficacy of bimonthly in elderly patients with colorectal cancer. J Clin Oncol 2006;24(25):4085-91. Abstract
O’Connell MJ et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502-7. Abstract
Roedel C et al. Cetuximab in combination with capecitabine, oxaliplatin and concomitant radiotherapy (Cet-Capox-RT) as preoperative therapy for rectal cancer. Proc ASTRO 2006;Abstract 147.
Saltz L et al. Bevacizumab in combination with XELOX or FOLFOX4: Updated efficacy results from XELOX-1/NO16966, a randomized phase III trial in first-line metastatic colorectal cancer. Proc ASCO 2007;Abstract 4028.
Sauer R et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731-40. Abstract
Willett C et al. Phase I/II study of neoadjuvant bevacizumab with radiation therapy and 5-fluorouracil in patients with rectal cancer: Initial results. Proc ASCO 2007; Abstract 4041.
